Precision BioSciences Inc. Common Stock (DTIL)
Stock · NASDAQ · Health Care
$7.78as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$7.25
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $191.45M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Precision BioSciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub
Precision BioSciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DTILPrecision BioSciences Inc. Common Stock$7.78▼ 7.38%Market cap $191.45MP/E —
- VYGRVoyager Therapeutics Inc. Common Stock$3.54▲ 2.17%Market cap $189.12MP/E —$2.94$5.55
- IVVDInvivyd Inc. Common Stock$0.9628▲ 6.98%Market cap $194.15MP/E —
- ARMPArmata Pharmaceuticals Inc. Common Stock$5.24▼ 3.50%Market cap $172.54MP/E —$2.4$16.34
- LENZLENZ Therapeutics Inc. Common Stock$5.12▲ 6.34%Market cap $163.67MP/E —$4.54$50.4
- MOLNMolecular Partners AG American Depositary Shares$4.5▼ 3.27%Market cap $163.47MP/E —$2.66$3.96
- CRBUCaribou Biosciences Inc. Common Stock$1.62▼ 2.41%Market cap $162.66MP/E —$1.38$3.54
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DTIL Precision BioSciences Inc. Common Stock | $191.45M | — | $7.78 | ▼ 7.38% | |
| VYGR Voyager Therapeutics Inc. Common Stock | $189.12M | — | $3.54 | ▲ 2.17% | $2.94$5.55 |
| IVVD Invivyd Inc. Common Stock | $194.15M | — | $0.9628 | ▲ 6.98% | |
| ARMP Armata Pharmaceuticals Inc. Common Stock | $172.54M | — | $5.24 | ▼ 3.50% | $2.4$16.34 |
| LENZ LENZ Therapeutics Inc. Common Stock | $163.67M | — | $5.12 | ▲ 6.34% | $4.54$50.4 |
| MOLN Molecular Partners AG American Depositary Shares | $163.47M | — | $4.5 | ▼ 3.27% | $2.66$3.96 |
| CRBU Caribou Biosciences Inc. Common Stock | $162.66M | — | $1.62 | ▼ 2.41% | $1.38$3.54 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- iECURE Announces Updated Safety And Metabolic Control Data From Phase 1/2 Trial Of ECUR-506 In Neonatal-Onset OTC Deficiency To Be Presented August 27 At SSIEM SymposiumBenzinga · 8/20/2026
- Precision BioSciences: Promising HBV Editing EvidenceSeekingAlpha · 8/18/2026
- Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum ScreenChartMill · 8/8/2026
- HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price TargetBenzinga · 8/3/2026
Insider Activity
Insider Actions →Acquired
1.14M
Disposed
0
- Brown Melinda · June 3, 2026 · Grant21.0K
- Frankel Stanley · June 3, 2026 · Grant21.0K
- Germano Geno J · June 3, 2026 · Grant21.0K
- Pire Shari Lisa · June 3, 2026 · Grant21.0K
- Buehler Kevin · June 3, 2026 · Grant21.0K
- SMITH J. JEFFERSON · June 1, 2026 · Grant57.4K
- Scimeca Dario · June 1, 2026 · Grant107.6K
- Kelly John Alexander · June 1, 2026 · Grant193.7K
- Michael Amoroso · June 1, 2026 · Grant573.9K
- Buehler Kevin · May 20, 2026 · Option Exercise21.0K
- Frankel Stanley · May 20, 2026 · Option Exercise21.0K
- Brown Melinda · May 20, 2026 · Option Exercise21.0K
- Pire Shari Lisa · May 20, 2026 · Option Exercise21.0K
- Germano Geno J · May 20, 2026 · Option Exercise21.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 16.00M
- Total value held
- $87.07M
- Institutional holders
- 75
Top holders this quarter
- Unknown2.24M
- Unknown2.23M
- Unknown1.97M
- Unknown1.66M
- Unknown1.07M
- Unknown995.4K
- Unknown985.1K
- Unknown910.7K
- Unknown597.9K
- Unknown415.7K
See the full, filterable feed with live charts on the MarketWall dashboard.